Immunotherapy for Hepatocellular Carcinoma: A 2021 Update

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common liver malignancy associated with poor prognosis. Treatment options are limited partially due to resistance to traditional chemotherapeutic agents. Immunotherapy has changed the treatment landscape in metastatic and recurrent solid tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Kole, Christo, Charalampakis, Nikolaos, Tsakatikas, Sergios, Vailas, Michail, Moris, Dimitrios, Gkotsis, Efthymios, Kykalos, Stylianos, Karamouzis, Michalis V., Schizas, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600093/
https://www.ncbi.nlm.nih.gov/pubmed/33020428
http://dx.doi.org/10.3390/cancers12102859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600093/
https://www.ncbi.nlm.nih.gov/pubmed/33020428
http://dx.doi.org/10.3390/cancers12102859

Ejemplares similares